Abstract
The etiologic diagnosis of hirsutism is often difficult. Previous studies have reported normal basal androgen and SHBG concentrations in 33–50% of hirsute women, suggesting the presence of an “idiopathic” form of hirsutism as the most frequent cause of this problem. The recent use of GnRH-analogues together with the corticotropin stimulation test allows better understanding of whether the cause of hirsutism is androgen excess and, if so, whether the origin of the latter is ovarian, adrenal or both. The present study evaluated adrenal and ovarian function in 48 young hirsute women as well as in 78 normal women matched for body mass index and age, who acted as control group. To determine ovarian function, a single 100-μg dose of GnRH analogue triptorelin was injected sc; thereafter, gonadotropins, 17-hydroxyprogesterone (17-OHP), Δ4-androstenedione (Δ4), total testosterone (T) and estradiol were determined. To better understand the adrenal function, 250 μg of 1,24 ACTH were administrated as iv infusion for 5 h, and plasma cortisol (F), 17-OHP, Δ4, DHEAS, T, 11-desossicortisol were measured. The combined use of these two stimulation tests was able to detect mild to moderate abnormalities in the steroidogenesis of ovaries alone (23%), adrenals alone (16.6%), or both (35.4%) in most hirsute women (75%) with otherwise normal baseline androgen concentrations. In particular, patients showed significantly increased responses of 17-OHP, Δ4, total T, 11-desossicorti-sol, and F to 1,24-ACTH administration. Moreover, they also had significantly higher 17-OHP and T responses to triptorelin. In conclusion, milder forms of functional ovarian and/or adrenal hyperandrogenism, similar to those found in clearly hyperandrogenic women, were observed and could be an underlying mechanism of idiopathic hirsutism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Valentino R., Tommaselli A.P., Savastano S., Dorato M., Rossi R., Lombardi G. Different dysregulation in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from Southern Italy. Fertil. Steril. 1997, 682: 36–41.
Darendeliler F., Bas F., Balaban S., Bundak R., Demirkol D., Saka N., Gunoz H. Spironolactone therapy in hypertrichosis. Eur. J. Endocrinol. 1996, 135: 604–608.
Horton R., Lobo R. Peripheral androgens and the role of androstanediol glucuronide. Clin. Endocrinol. Metab. 1986, 15: 293–306.
Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 1961, 21: 1440.
Rittmaster R.S. Clinical relevance of testosterone and dihydrotesto-sterone metabolism in women. Am. J. Med. 1995, 98 (Suppl.): 17S–21S.
Paulson R.J., Serafini P.C., Catalino J.A., Lobo R.A. Measurements of 3α, 17β-androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity. Fertil. Steril. 1986, 46: 222–226.
Glickman S.P., Rosenfield R.L. Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J. Invest. Dermatol. 1984, 82: 62–66.
Rittmaster R.S., Zwicker H., Thompson D.L., Konok G., Norman R.W. Androstanediol glucuronide production in human liver, prostate and skin. Evidence for the importance of the liver 5α-reduced androgen metabolism. J. Clin. Endocrinol. Metab. 1993, 76: 977–982.
Vottero A., Stratakis C.A., Ghizzoni L., Longui C.A., Karl M., Chrousos G.P. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. J. Clin. Endocrinol. Metab. 1999, 84: 1091–1095.
Sawaya M.E., Shalita A.R. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J. Cutan. Med. Surg. 1998, 3: 9–15.
Escobar-Morreale H.F., Serrano-Gotarredona J., Garcìa-Robles R., Sancho J., Varela C. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 1997, 46: 902–907.
Erel C.T., Senturk L.M., Oral E., Mutlu H., Colgar U., Seysoglu H., Ertungealp E. Results of the ACTH stimulation test in hirsute women. J. Reprod. Med. 1999, 44: 247–252.
Barnes R.B., Rosenfield R.L., Burnstein S., Ehrman D.A. Pituitary-ovarian response to Nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 1989, 320: 559–565.
Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med. 1992, 327: 157–162.
Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 1995, 16: 322–351.
Rosenfield R.L., Barnes R.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c 17α as the cause of polycystic ovary syndrome. Fertil. Steril. 1990, 53: 785–791.
Rittmaster R.S., Thompson D.L. Effects of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J. Clin. Endocrinol. Metab. 1990, 70: 1096–1102.
Billings E.L., Brown J.B., Billings J.J., Burger H.G. Symptoms and hormonal changes accompanying ovulation. Lancet 1972, 1: 282–284.
Adams J., Franks S., Polson D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985, ii: 1375–1379.
Nieman L., Cutler G.B. Jr. Cushing’s syndrome. In: DeGroot L.J., Besser M., Burger H.G., Loriaux D.L., Marshall J.C., Odell W.D., Potts J.T. Jr., Rubenstein A.H. (Eds.), Endocrinology. W.B. Saunders Company, Philadelphia, 1995, p. 1741.
New M.I., Lorenzen F., Lener A.J., Kohn B., Oberfield S.E., Pollack M.S., Dupont B., Stoner E., Levy D.J., Pang S., Levine L.S. Genotyping steroid 21-hydroxylase deficiency. Hormonal reference data. J. Clin. Endocrinol. Metab. 1983, 57: 320–325.
Eldar Geva T., Hurwitz A., Vecsei P., Palti Z., Mildwidsky A., Rosler A. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N. Engl. J. Med. 1990, 323: 855–863.
De Simone G., Tommaselli A.P., Rossi R., Valentino R., Lauria R., Scopacasa F., Lombardi G. Partial deficiency of adrenal 11 β-hydroxylase. A possible cause of primary hypertension. Hypertension 1985, 7: 204–210.
Sakkal-Alkaddour H., Zhang L, Yang X., Chang Y.T., Kappy M., Slover R.S., Jorgensen V., Pang S. Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated ΔA5-steroid levels. J. Clin. Endocrinol. Metab. 1996, 81: 3961–3965.
Polson D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries — A common finding in normal women. Lancet 1988, i: 870–872.
Werner S., Thorèn M., Gustafsson J.A., Brönnegård M. Glucocorticoid receptor abnormalities in fibroblasts from patients with idiopathic resistance to dexamethasone diagnosed when evaluated for adrenocortical disorders. J. Clin. Endocrinol. Metab. 1992, 75: 1005–1009.
Azziz R., Bradley E.L., Potter H.D., Boots L. Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J. Clin. Endocrinol. Metab. 1995, 80: 400–405.
Barnes R.L., Ehrmann D.A., Brigell D.F., Rosenfield R.L. Ovarian steroidogenic responses to the gonadotropin-releasing hormone agonist nafarelin in hirsute women thought to have 3β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 1993, 76: 450–455.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rossi, R., Tauchmanovà, L., Luciano, A. et al. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism. J Endocrinol Invest 24, 491–498 (2001). https://doi.org/10.1007/BF03343881
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343881